• Thiazovivin (A5506): ROCK Inhibitor for Stem Cell Workflows

  2026-07-28

  Thiazovivin is a selective ROCK inhibitor optimized for enhancing induced pluripotent stem cell (iPSC) generation and supporting human embryonic stem cell (hESC) survival after dissociation. It should be used in research workflows requiring robust cell viability and reprogramming efficiency, but is not suitable for diagnostic or medical applications. Long-term storage of prepared solutions and off-label clinical use are not recommended.

• Phosbind Biotin: Redefining Phosphorylated Protein Detection

  2026-07-27

  Explore how Phosbind Biotin, leveraging dinuclear metal complex phosphate binding, sets a new benchmark for Western Blot detection of phosphorylated proteins. This article uniquely dissects its mechanism, practical protocol choices, and insights from recent plant stress research.

• PF-562271 HCl: Precision Tools for FAK/Pyk2 Inhibition in Ca

  2026-07-27

  Explore how PF-562271 HCl, a potent FAK/Pyk2 inhibitor, advances cancer research through exceptional selectivity and protocol flexibility. This in-depth analysis highlights key assay design insights and practical considerations for maximizing experimental success.

• Scenario-Based Insights: FITC Goat Anti-Mouse IgG (H+L) Anti

  2026-07-26

  This article delivers scenario-driven, evidence-based guidance for using the FITC Goat Anti-Mouse IgG (H+L) Antibody (SKU K1201) in cell viability and immunofluorescence assays. Designed for biomedical researchers and lab technicians, it details how this fluorescein-conjugated secondary antibody enhances reproducibility, sensitivity, and workflow security in mouse IgG detection.

• AI-10-49: Transforming CBFβ-SMMHC Inhibition in AML Research

  2026-07-25

  AI-10-49, a selective CBFβ-SMMHC inhibitor, enables precision targeting of leukemic fusion proteins and restoration of RUNX1 function. This article provides a practical, data-driven walkthrough for integrating AI-10-49 into acute myeloid leukemia research workflows, with actionable protocol guidance and troubleshooting strategies.

• RepSox: Advancing iPSC Platelet Differentiation & TGF-β Inhi

  2026-07-24

  This thought-leadership article explores RepSox—a potent, selective ALK5 inhibitor—and its mechanistic impact on TGF-β signaling, iPSC reprogramming, and next-generation platelet production. Integrating recent peer-reviewed advances and expert workflow insights, we dissect protocol optimization, translational challenges, and strategic guidance for researchers driving scalable, cost-effective cell therapy solutions.

• Calpain Inhibitor I, ALLN: Technical Guidance for Lab Resear

  2026-07-24

  Calpain Inhibitor I, ALLN offers targeted inhibition of calpain and cathepsin proteases to support precise modulation in apoptosis assays, inflammation, and ischemia-reperfusion injury models. This compound should not be used in diagnostic or therapeutic contexts and requires careful handling to maintain stability and reproducibility.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-07-23

  Anlotinib hydrochloride is a novel multi-target tyrosine kinase inhibitor with superior anti-angiogenic properties compared to established agents. It selectively inhibits VEGFR2, PDGFRβ, and FGFR1 at nanomolar potency, blocking downstream ERK signaling and suppressing endothelial cell migration and tube formation. Its pharmacokinetic and toxicological profile supports robust applications in advanced cancer research assays.

• Optimized Sulfonamides Target TB With Lower CYP2C9 Inhibitio

  2026-07-23

  This study details the rational design and synthesis of sulfaphenazole-derived sulfonamides with potent antimycobacterial activity and minimized CYP2C9 inhibition. These findings advance the development of improved tuberculosis treatments with reduced risk of drug-drug interactions.

• Placebo-Controlled Double-Blind Trial Validates Mianserin HC

  2026-07-22

  This double-blind, placebo-controlled trial provides robust clinical evidence that Mianserin Hydrochloride exerts significant antidepressant and sleep-improving effects in depressed inpatients. The findings clarify its mechanistic and practical value for researchers studying serotonin receptor antagonism and depressive disorder therapeutics.

• 2-Deoxy-D-glucose: Precision Glycolysis Inhibition in Cancer

  2026-07-22

  2-Deoxy-D-glucose (2-DG) is a benchmark glycolysis inhibitor that empowers researchers to dissect metabolic vulnerabilities in cancer, viral infections, and immune modulation. This article translates the latest mechanistic findings and protocol refinements into actionable guidance, spotlighting real-world troubleshooting and cross-domain applications.

• Paclitaxel (Taxol): Targeting Senescence for Next-Gen Cancer

  2026-07-21

  Explore how Paclitaxel (Taxol) uniquely enables advanced cancer research by dissecting senescence, cell cycle arrest, and tumor microenvironment remodeling. This in-depth guide delivers new insights for experimental design beyond standard microtubule stabilization.

• Angiotensin 1/2 (1-6): Precision in Renin-Angiotensin System

  2026-07-21

  Angiotensin 1/2 (1-6) empowers cardiovascular and renal researchers with unmatched specificity in dissecting vascular tone and signaling pathways. Its robust solubility and reproducible activity make it an indispensable asset for advanced studies and emerging cross-domain applications.

• Reimagining Reporter mRNA: mCherry Advances for Translationa

  2026-07-20

  This article offers translational researchers a mechanistic and strategic deep dive into the evolving landscape of reporter gene mRNA technologies. It highlights how innovations in mRNA chemistry—exemplified by APExBIO's EZ Cap™ mCherry mRNA (5mCTP, ψUTP)—enable immune-evasive, highly stable, and reproducible red fluorescent protein expression. By bridging the latest findings in nanoparticle loading and cellular workflows, the discussion delivers actionable guidance for next-generation assay design and therapeutic exploration.

• Mouse Tissue Lysis Kit (K1038): Practical Protocol and QC Gu

  2026-07-20

  The Mouse Tissue Lysis Kit (K1038) offers a rapid approach for lysing mouse tissues to directly prepare DNA suitable for genotyping assays, bypassing laborious DNA extraction steps. This kit is designed for research use in molecular biology and should not be applied to diagnostic or clinical workflows.

453 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page